王书君 & 经莉. (2026). miR-125b 通过靶向 BCL-2 逆转宫颈癌 SiHa 细胞顺铂耐药的机制. Journal of International Obstetrics & Gynecology, 53(4), 390. https://doi.org/10.12280/gjfckx.20260116
Chicago Style (17th ed.) Citation王书君 and 经莉. "MiR-125b 通过靶向 BCL-2 逆转宫颈癌 SiHa 细胞顺铂耐药的机制." Journal of International Obstetrics & Gynecology 53, no. 4 (2026): 390. https://doi.org/10.12280/gjfckx.20260116.
MLA (9th ed.) Citation王书君 and 经莉. "MiR-125b 通过靶向 BCL-2 逆转宫颈癌 SiHa 细胞顺铂耐药的机制." Journal of International Obstetrics & Gynecology, vol. 53, no. 4, 2026, p. 390, https://doi.org/10.12280/gjfckx.20260116.
Warning: These citations may not always be 100% accurate.
